Suministro de Imiglucerasa(DOE), Agalsidasa Beta(DOE), Alirocumab(DOE), Sarilumab(DOE), Eliglustat(DOE), Aflibercept(DOE) Intravenoso y Laronidasa(DOE)
Deadline:N/A
Tender information
Araba/Álava
Type
Contract award
Procedure
Negotiated without a call for competition
Ref. number
2026/00591
Estimated value
€16,775,052
Duration
5 years
Suministro de Imiglucerasa(DOE), Agalsidasa Beta(DOE), Alirocumab(DOE), Sarilumab(DOE), Eliglustat(DOE), Aflibercept(DOE) Intravenoso y Laronidasa(DOE)
1 - L1_IMIGLUCERASA (DOE)
L1_IMIGLUCERASA (DOE)
2 - L2_AGALSIDASA BETA (DOE)
L2_AGALSIDASA BETA (DOE)
3 - L3_ALIROCUMAB (DOE)
L3_ALIROCUMAB (DOE)
4 - L4_SARILUMAB (DOE)
L4_SARILUMAB (DOE)
5 - L5_ELIGLUSTAT (DOE)
L5_ELIGLUSTAT (DOE)
6 - L6_AFLIBERCEPT (DOE) INTRAVENOSO
L6_AFLIBERCEPT (DOE) INTRAVENOSO
7 - L7_LARONIDASA (DOE)
L7_LARONIDASA (DOE)
Buyer
OSAKIDETZA - Servicio Vasco de Salud - Organización Central
Contract award
Documents
Contract award
Buyer
OSAKIDETZA - Servicio Vasco de Salud - Organización Central
Contract awarded
Important dates
31 Jul - Publication date
Unlock Full Access with Mercell Bidding Business Plus